Prostate Cancer - Results from #20520

Practice patterns of urologists in managing Korean men aged 40 years or younger with high serum prostate-specific antigen levels - Abstract May 22, 2014

Treatment plan comparison between stereotactic body radiation therapy techniques for prostate cancer: Non-isocentric CyberKnife versus isocentric RapidArc - Abstract May 22, 2014

Exploring the role of the partner in couples' sexual recovery after surgery for prostate cancer - Abstract May 22, 2014

Skeletal-related events and mortality among older men with advanced prostate cancer - Abstract May 22, 2014

Screening and detection advances in magnetic resonance image-guided prostate biopsy - Abstract May 21, 2014

Management of an increasing prostate-specific antigen level after negative prostate biopsy - Abstract May 21, 2014

Prolaris® test predicts mortality risk in prostate cancer biopsy study May 21, 2014

Treatment with PROVENGE ® (sipuleucel-T) induces antigen spread associated with overall survival benefits in advanced prostate cancer data from ProACT, IMPACT and PROCEED to be presented at the 2014 American Urological Association (AUA) annual meeting May 21, 2014

Decision making and prostate cancer screening - Abstract May 20, 2014

Emerging PSA-based tests to improve screening - Abstract May 20, 2014

Beckman Coulter’s phi named in NCCN Guidelines as a recommended diagnostic test for early prostate cancer detection May 20, 2014

Metabolic syndrome disorders, diet may boost prostate cancer risk May 20, 2014

International perspectives on screening - Abstract May 19, 2014

The politics of prostate cancer screening - Abstract May 19, 2014

The predictive powers of PSA: Working smarter to detect prostate cancer May 19, 2014

AUA announces amendments to castration resistant prostate cancer clinical practice guideline May 18, 2014

Dogs detect prostate cancer in men at a remarkably high rate of accuracy May 18, 2014

European Urology published groundbreaking results from three studies demonstrating Genomic Health's Oncotype DX® test predicts prostate cancer aggressiveness at diagnosis May 17, 2014

Benefits, outcomes and limitations of active surveillance for prostate cancer May 17, 2014

Prognostic and predictive value of plasma testosterone levels in patients receiving first-line chemotherapy for metastatic castrate-resistant prostate cancer - Abstract May 16, 2014

Page 1027 of 1435